EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion

Lu Gao iD, Xiaohui Cai iD, Yalong Dang iD

Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-11

DOI: 10.2147/dddt.s604539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Lu Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sanmenxia Central Hospital, Henan University of Science and Technology, Sanmenxia, 472000, People's Republic of China. Hauptthemen laut MEDLINE: Dexamethasone, Macular Edema, Retinal Vein Occlusion, Ranibizumab. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneMacular EdemaRetinal Vein OcclusionRanibizumabAngiogenesis InhibitorsHumansRetrospective StudiesFemaleDrug ImplantsIntravitreal InjectionsMaleAgedDrug Therapy, CombinationMiddle AgedVisual AcuityTreatment Outcome

Stichwörter der Autor:innen

VEGFdexamethasonemacular edemaranibizumabretinal vein occlusionsequential therapy

Substanzen

DexamethasoneRanibizumabDrug ImplantsAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Sanmenxia Central Hospital, Henan University of Science and Technology, Sanmenxia, 472000, People's Republic of China.
  • The First Affiliated Hospital of Henan University of Science and Technology; Department of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471000, People's Republic of China.
  • Sanmenxia Eye Hospital; Henan International Joint Laboratory of Glaucoma Aqueous Humor Drainage, Sanmenxia, 472000, People's Republic of China.

ORCID-Profile: Lu Gao, Xiaohui Cai, Yalong Dang

Zitieren

APA

Gao, L., Cai, X., & Dang, Y. (2026). Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion. Drug Design, Development and Therapy, Volume 20, 1-11. https://doi.org/10.2147/dddt.s604539

Vancouver

Gao L, Cai X, Dang Y. Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion. Drug Design, Development and Therapy. 2026;Volume 20:1-11. doi:10.2147/dddt.s604539

BibTeX
@article{Gao2026,
  author = {Gao, Lu and Cai, Xiaohui and Dang, Yalong},
  title = {Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--11},
  doi = {10.2147/dddt.s604539}
}
Kostenlos starten →